Bioabsorbable polymer companies develop materials designed to degrade safely within the body after performing a temporary medical function. These polymers are used across drug delivery, tissue repair, surgical devices and regenerative medicine.
This category includes companies working on:
Browse 9 UK bioabsorbable polymer companies below.
Controlled-release orthobiologics for spinal fusion and bone repair
Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery. Its proprietary Programmed Drug Release platform…
Bio-based polyurethane alternatives from agricultural waste and seaweed
AlGreen is an industrial biotechnology company developing bio-based alternatives to petroleum-derived polyurethanes, which account for approximately 8% of global plastics. Using…
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using…
Asymmetric biomaterial skin substitutes for acute and chronic wounds
Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material…
Oxygen-generating nanoparticles to overcome hypoxia in solid tumours
StimOxyGen is a preclinical-stage biotechnology company developing pH-responsive nanoparticle formulations to address tumour hypoxia, a major barrier to effective cancer…
Synthetic platform for precision delivery of biologics in tissue repair
Renovos Biologics is a biotech company developing precision delivery technologies for regenerative medicine, drawing on decades of academic research in skeletal stem cells,…
Bioabsorbable polymer biomaterials for implantable medical devices
4D Medicine is a UK-based biotechnology company developing bioabsorbable polymer biomaterials for use in implantable medical devices and controlled drug delivery systems. The…
Silicon-based RNA delivery platform for rare disease therapeutics
SiSaf is a biopharmaceutical company developing RNA therapeutics using its proprietary platform, which combines bioabsorbable silicon with organic lipid materials to improve the…
Sustained-release ocular drug delivery for retinal disease
Re-Vana Therapeutics is a biotechnology company developing sustained-release drug delivery technologies for the treatment of serious retinal diseases. Its biodegradable hydrogel…